Evelo Biosciences, Inc.
Records under this name other than the patents Evelo Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Evelo Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,603,878 | Probiotic and Prebiotic Compositions, and Methods of Use Thereof for Treatment and Prevention of Graft Versus Host Disease now held by Pharmabiome AG In force · Medium confidence | In force | Medium confidence | |
| US 9,610,307 | Probiotic Compositions Containing Clostridiales for Inhibiting Inflammation now held by Pharmabiome AG In force · High confidence | In force | High confidence | |
| US 10,869,903 | Probiotic and Prebiotic Compositions, and Methods of Use Thereof for Treatment and Prevention of Graft Versus Host Disease now held by Pharmabiome AG In force · Medium confidence | In force | Medium confidence | |
| US 11,672,834 | Probiotic and Prebiotic Compositions, and Methods of Use Thereof for Modulation of the Microbiome now held by Pharmabiome AG In force · High confidence | In force | High confidence | |
| US 10,980,845 | Probiotic and Prebiotic Compositions, and Methods of Use Thereof for Modulation of the Microbiome now held by Pharmabiome AG In force · High confidence | In force | High confidence | |
| US 11,607,432 | Probiotic Compositions Containing Clostridiales for Inhibiting Inflammation now held by Pharmabiome AG In force · Medium confidence | In force | Medium confidence | |
| US 11,612,622 | Probiotic Compositions Containing Clostridiales for Inhibiting Inflammation now held by Pharmabiome AG In force · Medium confidence | In force | Medium confidence | |
| US 11,266,700 | Compositions and Methods for Treating Immune Disorders Using Immune Modulating Lactococcus Bacteria Strains Lapsed on the fee record Ended Mar 8, 2026 · High confidence | Lapsed on the fee record | Ended Mar 8, 2026 | High confidence |
| US 11,241,461 | Treating Cancer Using a Blautia Strain Lapsed on the fee record Ended Feb 8, 2026 · High confidence | Lapsed on the fee record | Ended Feb 8, 2026 | High confidence |
| US 11,090,341 | Compositions and Methods for Treating Cancer and Immune Disorders Using Veillonella Bacteria Lapsed on the fee record Ended Aug 17, 2025 · High confidence | Lapsed on the fee record | Ended Aug 17, 2025 | High confidence |